We are live on ! Find out more
MRND

IQ U.S. Mid Cap R&D Leaders ETF

Delisted

MRND was delisted on the 12th of December, 2023.

2 hedge funds and large institutions have $200K invested in IQ U.S. Mid Cap R&D Leaders ETF in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 22 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

98% less capital invested

Capital invested by funds: $9.62M → $200K (-$9.42M)

Holders
2
Holders Change
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$11K

Top Sellers

Rank Fund Capital Flow
1
MSL
Mackay Shields LLC
New York
-$4.81M
Name Holding Trade Value Shares
Change
Change in
Stake
NYLIM
1
New York Life Investment Management
New York
$190K
UBS Group
2
UBS Group
Switzerland
$10K +$11K +498 New
MSL
3
Mackay Shields LLC
New York
-$4.81M -190,000 Closed

MRND Hedge Fund Activity: Q2 2022 in Review

2 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in IQ U.S. Mid Cap R&D Leaders ETF (MRND) for Q2 2022, worth a combined $200K — down 98% from $9.62M a quarter earlier.

Fund positioning in MRND was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $11K. The largest seller was Mackay Shields LLC, exiting entirely with an estimated $4.81M sold.

  • 2 institutional investors held IQ U.S. Mid Cap R&D Leaders ETF (MRND) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $200K of IQ U.S. Mid Cap R&D Leaders ETF stock for Q2 2022, down 98% quarter-over-quarter.
  • 1 fund opened new IQ U.S. Mid Cap R&D Leaders ETF positions in Q2 2022 and 1 closed out, a net change of 0 holders.
  • The largest IQ U.S. Mid Cap R&D Leaders ETF buyer in Q2 2022 was UBS Group, an estimated $11K added.
  • The largest IQ U.S. Mid Cap R&D Leaders ETF seller in Q2 2022 was Mackay Shields LLC, an estimated $4.81M sold.

Based on aggregated 13F filings for Q2 2022.